Study reveals developing countries with recipe for thriving health biotech ...( ineering principles to the processing o...)

Case studies relied on multiple sources of information. As many as 30 to 40 key people in the health biotech sector including government, private and public research institutions, educational institutions, the private-sector and non-governmental organizations in each country sources were interviewed. Published papers and books, background and policy documents, and patent data were also analyzed.

The findings were subsequently validated through verification of the case studies with interview participants and presentation at the Canadian Program on Genomics and Global Health's (CPGGH) Genomic Policy Executive Courses, including meetings held for the Eastern Mediterranean, Latin America and Caribbean, East Asia, and India. Finally, the CPGGH held a 2-day workshop from May 31 to June 1, 2004, with the collaborators, researchers and invited external experts to discuss and exchange ideas on the case studies.

Says Keith Stewart, Director of McLaughlin Centre for Molecular Medicine: "The McLaughlin-Rotman Centre for Global Health an initiative of the McLaughlin Center for Molecular Medicine has a mission to accelerate the introduction of molecular discovery into clinical care. This by its nature requires that scientific and clinical programs based on biotechnology are deployable and economically viable not only in the industrialized world but also in resource-poor settings studying the impact of biotechnology in developing countries is then of high importance to us and we are pleased to have supported this important effort."

'"/>

Contact: Juliet Heller
juliet@julietheller.co.uk
44-1-621-868-083
University of Toronto Joint Center for Bioethics
6-Dec-2004